Abbott and MedImpact PBM cooperating in H. pylori eradication therapy.
ABBOTT, MEDIMPACT PARTNERING ON H. PYLORI ERADICATION PROGRAM in an effort to get more managed care physicians and patients to use the combination therapy omeprazole (Astra Merck's Prilosec) and clarithromycin (Abbott's Biaxin) in the treatment of peptic ulcer disease. MedImpact VP-Disease State Management Robert Da Silva and Abbott National Managed Care Exec Vic Rosenshein discussed their partnership May 11 at the Academy of Managed Care Pharmacy's annual meeting in San Francisco.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth